InvestmentJun 15, 2026, 11:36 AM
Arcadia Biosciences Raises $4 Million in Private Placement
AI Summary
Arcadia Biosciences, Inc. announced the closing of a private placement of securities, raising approximately $4 million before expenses. The offering included pre-funded warrants and Series A-1 and Series A-2 preferred investment options to purchase common stock. The company intends to use the net proceeds for working capital and general corporate purposes. H.C. Wainwright & Co. served as the exclusive placement agent for the transaction.
Key Highlights
- Arcadia Biosciences secured approximately $4 million in a private placement.
- The placement involved pre-funded warrants and investment options to purchase common stock.
- Securities were sold at $1.0299 per unit, with gross proceeds expected around $4 million.
- The company plans to use the net proceeds for working capital and general corporate purposes.
- H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Price Impact
More from RKDA